Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Challenges to the Successful Introduction of Biotechnologies in Developing Countries

Challenges to the Successful Introduction of Biotechnologies in Developing Countries • • • PUBLIC HEALTH ETHICS VOLUME 1 NUMBER 2 2008 104–109 104 Challenges to the Successful Introduction of Biotechnologies in Developing Countries Stephen W. Jarrett ,UNICEF Corresponding author: Stephen W. Jarrett, Principal Adviser, UNICEF, 3 United Nations Plaza, New York, NY 10017, USA. Tel.: +1 212 326 7246; Fax: +1 212 326 7477; Email: sjarrett@unicef.org. The right to health means biotechnologies should be child mortality, improving maternal health and com- readily available to all, rich and poor alike. In the case bating HIV/AIDS, malaria and other diseases (United of vaccines, however, there is a significant divergence Nations, 2005). The challenge is to mitigate the risk that in availability between rich and poor countries, both in vaccination initiatives lose momentum before reaching number and types of vaccines. Reducing this divergence disadvantaged groups, resulting in a rise in coverage in- is a clear ethical challenge, so populations everywhere, equalities (Victora, C. G. et al. 2003). especially children, are equally protected from a range Presently, children in rich developed countries have of killer diseases, and mortality rates in children can access to a far greater and more sophisticated range of be significantly reduced. Incentives must be available for vaccines than children http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Public Health Ethics Oxford University Press

Challenges to the Successful Introduction of Biotechnologies in Developing Countries

Jarrett, Stephen W.
Public Health Ethics , Volume 1 (2) – Jul 21, 2008
Download PDF
6 pages

Loading next page...
 
/lp/oxford-university-press/challenges-to-the-successful-introduction-of-biotechnologies-in-m0kkyICzRw

References (12)

Publisher
Oxford University Press
Copyright
The Author 2008. Published by Oxford University Press. Available online at www.phe.oxfordjournals.org
Subject
Original Article
ISSN
1754-9973
eISSN
1754-9981
DOI
10.1093/phe/phn020
Publisher site
See Article on Publisher Site

Abstract

• • • PUBLIC HEALTH ETHICS VOLUME 1 NUMBER 2 2008 104–109 104 Challenges to the Successful Introduction of Biotechnologies in Developing Countries Stephen W. Jarrett ,UNICEF Corresponding author: Stephen W. Jarrett, Principal Adviser, UNICEF, 3 United Nations Plaza, New York, NY 10017, USA. Tel.: +1 212 326 7246; Fax: +1 212 326 7477; Email: sjarrett@unicef.org. The right to health means biotechnologies should be child mortality, improving maternal health and com- readily available to all, rich and poor alike. In the case bating HIV/AIDS, malaria and other diseases (United of vaccines, however, there is a significant divergence Nations, 2005). The challenge is to mitigate the risk that in availability between rich and poor countries, both in vaccination initiatives lose momentum before reaching number and types of vaccines. Reducing this divergence disadvantaged groups, resulting in a rise in coverage in- is a clear ethical challenge, so populations everywhere, equalities (Victora, C. G. et al. 2003). especially children, are equally protected from a range Presently, children in rich developed countries have of killer diseases, and mortality rates in children can access to a far greater and more sophisticated range of be significantly reduced. Incentives must be available for vaccines than children

Journal

Public Health Ethics – Oxford University Press

Published: Jul 21, 2008

There are no references for this article.